ArticleFrontiers in oncology2026
Psychosomatic symptom profiles and associated factors of clinically significant anxiety symptoms among breast cancer patients receiving chemotherapy: a multicenter cross-sectional study in China.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chemotherapy is a cornerstone of breast cancer treatment, but chemotherapy-induced adverse events and psychosocial factors often impair patients' quality of life and diminish its clinical benefit. Objective: To summarize the characteristics of psychosomatic symptoms during chemotherapy for breast cancer and identify associated factors for clinically significant anxiety symptoms. Methods: A multicenter cross-sectional study was conducted in four hospitals in China. Basic clinical data and medical history were collected for all participants. The 7-item Generalized Anxiety Disorder Scale (GAD-7) was adopted to evaluate clinically significant anxiety symptoms. The MD Anderson Symptom Inventory (MDASI) and the Symptom Assessment Scale for Breast Cancer Patients Undergoing Chemotherapy were used to collect and assess high-frequency psychosomatic distress. The Social Support Rating Scale (SSRS) measured objective support, subjective support, and utilization of social support, and the Resilience Scale Specific to Cancer (RS-SC) was used to evaluate psychological resilience. Univariate and multivariate binary logistic regression analyses were performed to screen associated factors for clinically significant anxiety symptoms, and Spearman's rank-order correlation was used to explore correlations between high-frequency psychosomatic symptoms and anxiety. Results: A total of 391 breast cancer patients undergoing chemotherapy were enrolled in this study. The total anxiety incidence was 43.99%, including mild (28.64%), moderate (12.53%), and severe anxiety (2.82%). Binary logistic regression analysis identified clinical stage and cumulative chemotherapy cycles as independent associated factors for anxiety in breast cancer patients during chemotherapy (all Conclusion: Observational findings from this study identify several characteristics associated with clinically significant anxiety among breast cancer patients receiving chemotherapy: younger age, low psychological resilience, poor KPS performance status, advanced clinical stage, and longer cumulative chemotherapy cycles. Difficulty initiating sleep, fatigue, and nausea show correlations with anxiety symptoms in this patient population. These findings highlight that physical symptom assessment and psychological screening should not be separated during clinical care for breast cancer patients undergoing chemotherapy, and provide observational evidence for developing integrated supportive care strategies in real-world oncology practice. Clinical Trial Registration: https://www.chictr.org.cn/, identifier ChiCTR2400086704.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.